In new Alzheimer's criteria, some see progress while others fear profit-driven ‘diagnostic creep' [CNN]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: CNN
has published the final version of its new diagnostic criteria for the disease. And for the first time, the criteria call on doctors diagnosing the disease to rely on biomarkers — pieces of beta amyloid and tau proteins picked up by lab tests or on brain scans — rather than pen-and-paper tests of memory and thinking. The idea behind the change, the authors say, is to catch the condition in its earliest and most treatable stages, even before symptoms develop. However, it also means people could be diagnosed with Alzheimer's based on a blood test alone, even if they don't have any memory difficulties. Biology should be the basis of the diagnosis, the authors argue, rather than symptoms. Furthermore, they say, just because a person doesn't have symptoms doesn't mean they won't develop them down the line. But the criteria have been criticized by outside experts and drug industry watchdog groups who point out that people can have beta amyloid proteins in their brains and blood withou
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Consumer Healthcare Market size is set to grow by USD 170.2 billion from 2024-2028, Awareness about lifestyle diseases boost the market, Technavio [Yahoo! Finance]Yahoo! Finance
- Heart Pump Device Market Research - Global Insights, Competitive Landscape, and Forecasts to 2030 [Yahoo! Finance]Yahoo! Finance
- Global Mechanical Circulatory Support Devices Market to Surge to USD 4.24 Billion by 2030, Driven by Technological Advancements and Rising Cardiovascular Disease Prevalence [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Evercore ISI from $125.00 to $120.00. They now have an "outperform" rating on the stock.MarketBeat
- Global Rapid Medical Diagnostic Kits Market Analysis, Competitive Strategies and Forecasts, 2024-2032: Revolutionizing Healthcare Delivery, Innovative Technologies Enhancing Speed and Accuracy [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 7/2/24 - Form 4
- 7/2/24 - Form 4
- 7/2/24 - Form 4
- ABT's page on the SEC website